Reuter James Wealth Management, LLC Biogen Inc. Transaction History
Reuter James Wealth Management, LLC
- $536 Million
- Q3 2024
A detailed history of Reuter James Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 648 shares of BIIB stock, worth $103,673. This represents 0.02% of its overall portfolio holdings.
Number of Shares
648
Previous 929
30.25%
Holding current value
$103,673
Previous $215,000
41.86%
% of portfolio
0.02%
Previous 0.16%
Shares
12 transactions
Others Institutions Holding BIIB
# of Institutions
1,035Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.67 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.61 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.33 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.18 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$821 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $23B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...